PUBLICATIONS · 27717299
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- N Engl J Med
- Publication date
- 2016 Dec 1
- First author
- Mirza MR
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Nat Rev Clin Oncol. 2017 Feb;14(2):71. doi: 10.1038/nrclinonc.2016.207.
- note
- Source null
- related pmid
- 27958296
- relationship
- Comment in
- citation
- N Engl J Med. 2016 Dec;375(22):2197-2198. doi: 10.1056/NEJMe1612843.
- note
- Source null
- related pmid
- 27959768
- relationship
- Comment in
- citation
- N Engl J Med. ;376(8):801. doi: 10.1056/NEJMc1616633.
- note
- Source null
- related pmid
- 28229583
- relationship
- Comment in
Authors and identifiers
- name
- Mirza MR
- type
- Author
- name
- Monk BJ
- type
- Author
- name
- Herrstedt J
- type
- Author
- name
- Oza AM
- type
- Author
- name
- Mahner S
- type
- Author
- name
- Redondo A
- type
- Author
- name
- Fabbro M
- type
- Author
- name
- Ledermann JA
- type
- Author
- name
- Lorusso D
- type
- Author
- name
- Vergote I
- type
- Author
- name
- Ben-Baruch NE
- type
- Author
- name
- Marth C
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Mirza MR
- type
- Author
- name
- Monk BJ
- type
- Author
- name
- Herrstedt J
- type
- Author
- name
- Oza AM
- type
- Author
- name
- Mahner S
- type
- Author
- name
- Redondo A
- type
- Author
- name
- Fabbro M
- type
- Author
- name
- Ledermann JA
- type
- Author
- name
- Lorusso D
- type
- Author
- name
- Vergote I
- type
- Author
- name
- Ben-Baruch NE
- type
- Author
- name
- Marth C
- type
- Author
- bibliography ids
- nci-bib-de06c92e073bbd94fb0006f3
- book metadata
- content sha256
- df1893ddd9f75c7104728505e1d342c609e17f2daa28dc8e187391d3dc3ff057
- document type
- citation
- dois
- 10.1056/NEJMoa1611310
- electronic publication date
- display
- 2016 Oct 7
- precision
- day
- year
- 2016
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:27717299
- immutable id
- pubmed:27717299@df1893ddd9f75c7104728505e1d342c609e17f2daa28dc8e187391d3dc3ff057
- journal
- abbreviation
- N Engl J Med
- issn electronic
- 1533-4406
- issn print
- 0028-4793
- issue
- 22
- name
- The New England journal of medicine
- nlm unique id
- 0255562
- pages
- 2154-2164
- volume
- 375
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Nat Rev Clin Oncol. 2017 Feb;14(2):71. doi: 10.1038/nrclinonc.2016.207.
- note
- Source null
- related pmid
- 27958296
- relationship
- Comment in
- citation
- N Engl J Med. 2016 Dec;375(22):2197-2198. doi: 10.1056/NEJMe1612843.
- note
- Source null
- related pmid
- 27959768
- relationship
- Comment in
- citation
- N Engl J Med. ;376(8):801. doi: 10.1056/NEJMc1616633.
- note
- Source null
- related pmid
- 28229583
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 27717299
- provenance
- batch id
- d649bcb2d98dbbacd53c
- provider
- NCBI PubMed ESummary
- record sha256
- a02121700728c1f57418509d74c478e8e7f37e8ac5b72ef374f456dad7b2d57f
- response sha256
- 26648a40f123f366675007f51cc29befd1f9a89273ca2da87c477c54d2d15d20
- retrieved at
- 2026-09-09T23:47:20.761544+00:00
- publication date
- display
- 2016 Dec 1
- precision
- day
- year
- 2016
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
Preserved source evidence · Not medical advice
Triangle